TY  - JOUR

T1  - Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients

JO  - BMJ Open

PY  - 2022/04/15

AU  - Brook MO

AU  - Hester J

AU  - Petchey W

AU  - Rombach I

AU  - Dutton S

AU  - Bottomley MJ

AU  - Black J

AU  - Abdul-Wahab S

AU  - Bushell A

AU  - Lombardi G

AU  - Wood K et al

ED  - 

DO  - DOI: 10.1136/bmjopen-2022-061864

PB  - BMJ

VL  - 12

IS  - 4

Y2  - 2024/10/22

ER  -